Ninety-six eyes of 48 patients with diabetes were studied. All
patients were diagnosed as having diabetic macular edema less severe
than CSME or as having untreatable CSME in one or both eyes by slit
lamp biomicroscopy (before data collection). Twelve eyes were excluded
for the following reasons: epiretinal fibrosis (n = 1),
missing OCT scan (n = 3), poor photograph quality (no stereo
effect) in Early-Treatment Diabetic Retinopathy Study (ETDRS) standard
field 2 (n = 4), poor photograph clarity due to lens
opacification (n = 4), and poor quality of the OCT scans due
to cataract (n = 1). Thus, a total of 84 eyes (43 right and
41 left eyes) in 47 patients underwent analysis. Baseline patient
characteristics were as follows: mean age, 53 years (range,
24.5–69.3); female-to-male ratio, 11:36; type I-to-type II diabetes
mellitus ratio, 7:40; mean duration of diabetes: type I, 13.8 years
(range, 2–26.7), type II, 23.5 years (range, 16–32.2).
CSME, meeting the ETDRS criteria of retinal thickening 500 μm or less
from the center of the fovea, was diagnosed in two eyes by fundus
examination.
4 Two eyes had previously had focal laser
photocoagulation for CSME, and both eyes were clinically assessed as
still having retinal thickening. Non-CSME (
n = 71; defined
as retinal thickening present at or within 2 disc diameters [DD] from
the fovea, but not meeting the criteria of CSME) or no definite retinal
thickening (
n = 9) was diagnosed in the remainder of the
eyes by fundus examination.
4
The control group consisted of 33 eyes in 25 healthy control subjects
(15 right eyes, and 18 left eyes): mean age, 48.2 years (range,
25–75); female-to-male ratio, 17:8.